Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ADIR patents new ellipticine/olivacine derivatives with excellent antitumor activity

March 2, 1999

Onyx and Bayer select lead ras-inhibiting compound

March 2, 1999

MedImmune and Ixsys form alliance for monoclonal antibody development

March 2, 1999

Photofrin approved in Finland

March 1, 1999

Valspodar plus chemotherapy in the treatment of relapsed or refractory AML

March 1, 1999

FDA advisory committee to review another NDA for Temodal in March

March 1, 1999

Magainin awarded SBIR grant for squalamine

March 1, 1999

Matrix begins treating patients in phase II study of FMdC

Feb. 26, 1999

Magainin reports interim results of squalamine trial

Feb. 26, 1999

FDA grants priority review status to U.S. Bioscience's sNDA for Ethyol

Feb. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...